Need a specific person's email?
Browse Juno Therapeutics, Inc.'s employee directory (about 94 employees) and reveal verified emails free.
Juno Therapeutics, Inc.'s most common email format is First.Last@junotherapeutics.com (ex. John.Doe@junotherapeutics.com), used for 94% of junotherapeutics.com addresses. Juno Therapeutics, Inc. uses 8 email patterns across 2 domains: junotherapeutics.com and bms.com. Percentages are the share of addresses within each domain.
| Format | Example | Share of junotherapeutics.com |
|---|---|---|
| First.Last@junotherapeutics.comMost common | John.Doe@junotherapeutics.com | |
| F.Last@junotherapeutics.com | J.Doe@junotherapeutics.com | |
| FirstLast@junotherapeutics.com | JohnDoe@junotherapeutics.com | |
| Last.First@junotherapeutics.com | Doe.John@junotherapeutics.com |
| Format | Example | Share of bms.com |
|---|---|---|
| First.Last@bms.comMost common | John.Doe@bms.com | |
| LastF@bms.com | DoeJ@bms.com | |
| First@bms.com | John@bms.com | |
| Last.First@bms.com | Doe.John@bms.com |
Browse Juno Therapeutics, Inc.'s employee directory (about 94 employees) and reveal verified emails free.
Biotechnology ResearchWashington, United States51-200 Employees
Juno Therapeutics, Inc., a biotechnology research company, is based in Seattle, Washington. It merged with Bristol Myers Squibb to form part of a larger biopharma organization. The combined entity concentrates on discovering, developing, and delivering medicines for patients with serious diseases, including cancer. Its focus is on serving patients and healthcare providers seeking therapies for serious illnesses, with cancer as a prominent program area. The arrangement places the company within Bristol Myers Squibb’s biopharma portfolio as a mid-sized, research-driven organization.
Most common format
First.Last@junotherapeutics.com
Example: John.Doe@junotherapeutics.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.